GAPDHP34

Across TCGA pan-cancer cohorts, GAPDHP34 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated GAPDHP34 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher GAPDHP34 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GAPDHP34 expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

KICH, COAD, and LGG are the cancer types where GAPDHP34 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
COAD	OS	Tertile	IV	0.180	0.670	.012	36	view →
LGG	DFS	Tertile	All	0.812	0.712	.019	30	view →
SARC	OS	Tertile	All	0.620	0.847	.004	18	view →
PCPG	OS	Tertile	All	0.925	1.000	.017	18	view →
THYM	DFS	Tertile	II,III,IV	0.075	0.843	<.001	9	view →
GBM	DFS	Tertile	All	0.089	0.300	.011	9	view →
SKCM	OS	Tertile	All	0.565	0.872	.024	6	view →
UCEC	DFS	Tertile	All	0.709	0.845	.037	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

GAPDHP34–KICH (DFS)

Open the KICH breakdown →